第二代窄带成像在高危患者早期胃癌检测中的多中心随机对照试验
这项开放标签多中心随机串联试验纳入高危胃癌患者,比较首次白光内镜与第二代窄带成像(2G-NBI)对早期胃癌检出率的影响,发现两组首次内镜检出率无显著差异,2G-NBI未提高检出率,但可疑病变阳性预测值略优。
要点
- 2G-NBI作为首次内镜并未提高高危患者早期胃癌检出率。
- 首次内镜对早期胃癌总体灵敏度仅75%,需改进。
- 2G-NBI对可疑病变的阳性预测值略高于白光内镜。
核心结论
- 在高危患者中,首次内镜对早期胃癌的总体灵敏度仅为75%,应予以提高。
- 2G-NBI相比常规白光内镜并未提高早期胃癌检出率。
- 2G-NBI略优的阳性预测值影响需进一步评估。
研究设计与样本
- 开放标签、随机、对照串联试验,在13家医院开展。
- 胃癌风险增高患者随机分为白光组(n=2258)和2G-NBI组(n=2265)。
- 白光组先白光后2G-NBI,2G-NBI组先2G-NBI后白光,由同一检查者操作。
- 两组疑似早期胃癌病变均活检,主要终点为首次检查中早期胃癌患者率。
主要发现
- 首次胃镜中,白光组检出早期胃癌44例(1.9%),2G-NBI组53例(2.3%),p=0.412。
- 事后分析中,第二次检查总体病变检出率为25%(n=36/145),组间无显著差异。
- 可疑病变早期胃癌阳性预测值白光组为13.5%(50/371),2G-NBI组为20.9%(59/282),p=0.015。
临床怎么用
- 高危患者首次内镜筛查时,不应依赖2G-NBI替代白光内镜以提高早期胃癌检出。
- 2G-NBI可能提高可疑病变的阳性预测值,但需进一步验证其临床影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Early detection of gastric cancer has been the topic of major efforts in high prevalence areas. Whether advanced imaging methods, such as second-generation narrow band imaging (2G-NBI) can improve early detection, is unknown. DESIGN: This open-label, randomised, controlled tandem trial was conducted in 13 hospitals. Patients at increased risk for gastric cancer were randomly assigned to primary white light imaging (WLI) followed by secondary 2G-NBI (WLI group: n=2258) and primary 2G-NBI followed by secondary WLI (2G-NBI group: n=2265) performed by the same examiner. Suspected early gastric cancer (EGC) lesions in both groups were biopsied. Primary endpoint was the rate of EGC patients in the primary examination. The main secondary endpoint was the positive predictive value (PPV) for EGC in suspicious lesions detected (primary examination). RESULTS: EGCs were found in 44 (1.9%) and 53 (2.3%; p=0.412) patients in the WLI and 2G-NBI groups, respectively, during primary EGD. In a post hoc analysis, the overall rate of lesions detected at the second examination was 25% (n=36/145), with no significant differences between groups. PPV for EGC in suspicious lesions was 13.5% and 20.9% in the WLI (50/371 target lesions) and 2G-NBI groups (59/282 target lesions), respectively (p=0.015). CONCLUSION: The overall sensitivity of primary endoscopy for the detection of EGC in high-risk patients was only 75% and should be improved. 2G-NBI did not increase EGC detection rate over conventional WLI. The impact of a slightly better PPV of 2G-NBI has to be evaluated further. TRIAL REGISTRATION NUMBER: UMIN000014503.
引用
- Yoshida N, Doyama H, Yano T, et al. Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging. Gut. 2020. PMID: 32241898. doi:10.1136/gutjnl-2019-319631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。